SYNERGY PHARMACEUTICALS DEL's ticker is SGYPQ and the CUSIP is 871639308. A total of 135 filers reported holding SYNERGY PHARMACEUTICALS DEL in Q2 2016. The put-call ratio across all filers is 0.58 and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q4 2018 | $242,000 | -95.8% | 2,123,397 | -37.7% | 0.00% | -100.0% |
Q3 2018 | $5,792,000 | -18.0% | 3,406,796 | -16.0% | 0.00% | 0.0% |
Q2 2018 | $7,060,000 | +0.8% | 4,057,270 | +6.0% | 0.00% | 0.0% |
Q1 2018 | $7,007,000 | -81.2% | 3,828,875 | -77.1% | 0.00% | -84.6% |
Q4 2017 | $37,207,000 | +205.7% | 16,684,860 | +297.5% | 0.01% | +160.0% |
Q3 2017 | $12,173,000 | -31.5% | 4,197,522 | +5.0% | 0.01% | -37.5% |
Q2 2017 | $17,782,000 | -30.2% | 3,996,010 | -26.9% | 0.01% | -38.5% |
Q1 2017 | $25,465,000 | +109.6% | 5,464,494 | +174.0% | 0.01% | +116.7% |
Q4 2016 | $12,147,000 | +125.5% | 1,994,522 | +104.0% | 0.01% | +100.0% |
Q3 2016 | $5,386,000 | +37.6% | 977,754 | -5.1% | 0.00% | +50.0% |
Q2 2016 | $3,914,000 | +150.3% | 1,029,948 | +81.7% | 0.00% | – |
Q1 2016 | $1,564,000 | -70.9% | 566,838 | -40.1% | 0.00% | -100.0% |
Q4 2015 | $5,368,000 | -13.6% | 946,621 | -19.2% | 0.00% | 0.0% |
Q3 2015 | $6,212,000 | -31.2% | 1,172,149 | +7.7% | 0.00% | -25.0% |
Q2 2015 | $9,031,000 | +383.5% | 1,088,139 | +169.2% | 0.00% | +300.0% |
Q1 2015 | $1,868,000 | +282.0% | 404,238 | +151.8% | 0.00% | – |
Q4 2014 | $489,000 | -62.3% | 160,534 | -65.5% | 0.00% | – |
Q3 2014 | $1,297,000 | -47.3% | 465,722 | -23.0% | 0.00% | – |
Q2 2014 | $2,461,000 | -25.0% | 604,873 | -2.1% | 0.00% | -100.0% |
Q1 2014 | $3,281,000 | +134.2% | 617,979 | +148.1% | 0.00% | – |
Q4 2013 | $1,401,000 | +96.5% | 249,057 | +59.6% | 0.00% | – |
Q3 2013 | $713,000 | -4.9% | 156,056 | -10.1% | 0.00% | – |
Q2 2013 | $750,000 | – | 173,619 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|